Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-21-000261
Filing Date
2021-02-16
Accepted
2021-02-16 16:33:58
Documents
43
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e2415_10q.htm   iXBRL 10-Q 582712
2 EXHIBIT 5.1 e2415_ex5-1.htm EX-5.1 13187
3 EXHIBIT 31.1 e2415_ex31-1.htm EX-31.1 8919
4 EXHIBIT 31.2 e2415_ex31-2.htm EX-31.2 9245
5 EXHIBIT 32.1 e2415_ex32-1.htm EX-32.1 6772
11 GRAPHIC image_001.jpg GRAPHIC 115293
12 GRAPHIC image_002.jpg GRAPHIC 78181
  Complete submission text file 0001731122-21-000261.txt   2948923

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE avxl-20201231.xsd EX-101.SCH 20614
7 XBRL CALCULATION FILE avxl-20201231_cal.xml EX-101.CAL 24069
8 XBRL DEFINITION FILE avxl-20201231_def.xml EX-101.DEF 76915
9 XBRL LABEL FILE avxl-20201231_lab.xml EX-101.LAB 181545
10 XBRL PRESENTATION FILE avxl-20201231_pre.xml EX-101.PRE 140537
13 EXTRACTED XBRL INSTANCE DOCUMENT e2415_10q_htm.xml XML 284451
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 21639446
SIC: 8731 Services-Commercial Physical & Biological Research